ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Ticker Update

Updates

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - BETAHISTINE DIHYDROCHLORIDE 8MG & 16MG TABLETS

Kent Pharmaceuticals Ltd has informed us that the affected batches above are contaminated with theophylline due to a cross-contamination issue identified with an excipient that was used in the manufacture of the finished product. Therefore, a decision has been taken to recall the affected batches

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-kent-pharmaceuticals-ltd-betahistine-dihydrochloride-8mg-and-16mg-tablets-el-20-a-55?utm_source=40c23525-b2da-4a2b-9a24-fc70e06dce17&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Pip code

Product description

Supplier

Batch Numbers

Alliance do not stock

Betahistine dihydrochloride 8mg Tablets

Kent Pharmaceuticals Ltd

EC10619

EC10719

EC10819

Alliance do not stock

Betahistine dihydrochloride 16mg Tablets

Kent Pharmaceuticals Ltd

GY11119

GY11219

GY11319

 

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

 

For stock control enquiries please contact customer.service@kent-athlone.com

 

For more information or medical information medical@kent-athlone.com

SUB-TYPE: CLASS 4 CAUTION IN USE

Company Led - Caution in use - Epistatus

Dear Healthcare Professional,

 

We have been made aware of Midazolam Maleate (Epistatus 10mg in 1ml Oromucosal Solution, Multidose bottle), unlicensed, emergency use medication for prolonged, acute, convulsive seizures: Potential risk of faulty and incorrectly engaged child - resistant container closure 

 

Please click here for further information 

 

Suspected drug reactions may also be reported to Veriton Pharma Ltd, Telephone +44 (0)1932 690325

 

For reporting of identified defects or queries, please contact Vertion Pharma Ltd, Telephone +44 (0) 1932690325 or email info veritonpharma.com

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - LARGACTIL AMP 50MG/2ML

Sanofi is recalling the below batches due to out of specification results obtained for the impurity chlorpromazine sulphoxide, which was suspected to be caused by increased oxidation as a result of higher oxygen content in the headspace of the ampoules. As a precautionary measure, the above batches are being recalled.

Pip code

Product description

Supplier

Batch Numbers

Recall Pip code

0154914

LARGACTIL AMP 50MG/2ML

SANOFI

A90142

A90143

N/A

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

 

For stock control enquiries please contact GB-CustomerServices@sanofi.com or phone 0800 854 430

 

For medical information enquiries please contact uk-medicalinformation@sanofi.com or call 0800 035 25 25

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - ABSTRAL TAB 200MCG (SCHEDULE 2 CD)

Kyowa Kirin Limited is recalling the below batches as a precautionary measure, due to the reports of double tablets in a single blister pocket. This is a follow up alert, following the issue of EL (20)A/34. Since this notification, Kyowa Kirin Limited have initiated corrective actions to resolve the issue. Complaint batches 608973601 and 608973602 were manufactured prior to the corrective actions being implemented...

PIP Code

Product Description

Supplier

Affected Batch

3460367

ABSTRAL TAB 200MCG 

KYOWA KIRIN        

608973601

3460375

ABSTRAL TAB 200MCG 

KYOWA KIRIN        

608973602

 

This product is a Schedule 2 Controlled Drug, so please use the Returns Portal for any recalled stock you may need to return to ensure there is authorisation to return. If you are unable to use the Returns Portal then your Alliance Healthcare driver will have a ‘Specialist Product Recall Book’ with them on Thursday 26th November and Friday 27th November  for completion and product uplift AM ONLY. Due to Covid 19, the driver will complete the form on your behalf.  They will ask for the quantity of stock you have to return and the name of the pharmacist. The driver will give you a copy of the completed form for your records.

If you need to return recalled stock from 28th November and are unable to use the Returns Portal please call Customer Services for authorisation to return.

Further Information

For Stock control enquiries please contact: Karen Murray, Commercial Manager

Telephone: +44 (0) 7712 001288

E-mail: karen.murray@kyowakirin.com

For Medical information enquiries please contact:

 

Medical Information Direct Line: + 44 (0)1896 664 000

E-mail: medinfo@kyowakirin.com

For Quality information please contact: Martin Smith (Responsible Person)

 

Telephone: +44 7904671807

E-mail: Martin.Smith@kyowakirin.com

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

This recall will remain open for 3 months from the date issued unless an alternative date is agreed by instigator. The closure of this will be 25/02/2021. Please note after this date customer returns may still be accepted but customers may not be credited

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - ANCOTIL 2.5 G/250 ML SOLUTION FOR INFUSION

: Mylan UK Healthcare Ltd has been informed of a non-compliance event which occurred during the most recent inspection at the contract manufacturing site for the above product in relation to product sterility. As a precautionary measure, remaining stock of the above batches are being recalled.

PIP Code

Product Description

Supplier

Affected Batch

2116432

ANCOTIL INF

MYLAN UK HEALTHCARE

113987

114626

114711

115051

F20CBJ

                                                               

For more information or medical information enquiries please contact Mylan UK Healthcare Ltd Medical Information Department on +44(0) 1707 853000 or via email at Info.uk@mylan.co.uk.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

 

This recall will remain open for 3 months from the date issued unless an alternative date is agreed by instigator. The closure of this will be 12/02/2021. Please note after this date customer returns may still be accepted but customers may not be credited.

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - Sodiofolin 50mg/ml Solution for Injection 100mg/2ml

medac Pharma LLP is recalling the below batch of products due to some inspected vials showing hairline damage to the shoulder of the vials. So far, the company has not received any reports of damage for marketed products. However, as this defect may impact on the sterility of the product, the above batch is being recalled as a precautionary measure

PIP Code

Product Description

Supplier

Affected Batch

Alliance do not stock

Sodiofolin 50mg/ml Solution for Injection 100mg/2ml

Medac Pharma LLP

B190132C

                                                               

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

 

For more information or medical information queries, please contact info@medacpharma.co.uk or telephone 01786 458086

 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Caution in use - Kolanticon Gel

Intrapharm Laboratories Ltd has informed us that there is a difference in dosage instructions between the carton and label. The Patient Information Leaflet (PIL) and bottle label contain the correct instructions.

PIP Code

Product Description

Supplier

Affected Batch

0077362

KOLANTICON GEL

INTRAPHARM LABORATORIES

AA0620

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will  be required to follow the instructions as per the drug alert.

This is a caution in use only we are not accepting stock returns.

For more information or medical information queries, please contact: medinfo@intrapharmlabs.com or telephone +44 (0)330 1359 437.

 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team

SUB-TYPE: CLASS 3 RECALL

Class 3 recall - Alfad 0.25 Microgram Capsules

Further to Drug Alert EL (20)A/46 issued on 29 September 2020 Theramex Ireland Ltd T/A Theramex HQ UK Ltd has informed us of an issue related to error in the decommissioning of a further batch as listed above. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘EXPORT’. Although there is no risk to product quality, any remaining stock should be quarantined and returnedThe affected products' details are as follows:

PIP Code

Product Description

Supplier

Affected Batch

7149503

ALFAD 0.25 MICROGRAM CAPSULES

THERAMEX

A04279A

 

Please note that Alliance do not stock the above products therefore we are not accepting returns on this recall.

 

For stock control enquiries please contact Theramex HQ UK Ltd Customer Services Team on 020 3962 5532.

 

For medical information enquiries please contact Theramex HQ UK Ltd Medical Information Department on 033 3009 6795.

 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

SUB-TYPE: CLASS 2 RECALL

COMPANY LED - CLASS 2 RECALL Class type: Company Led

Precautionary recall following mould being identified in a few jars of each batch.

 

The affected products' details are as follows:

PIP Code

Product Description

Supplier

Affected Batch

3735883

POTTERS MALT EXT & CLO ORIG

CEUTA

3M01134

3M01136

3M01137

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

SUB-TYPE: COMPANY-LED RECALL

Company Led Drug Alert Optiray 300mg & 350mg I-Ml Solution For Injection Class type: Company Led

Guerbet Laboratories Limited is recalling the above batches of products as a precautionary measure due to reports received from healthcare professionals on the difficulties in attaching the Luer lock adapter to the Luer tip of the pre-filled syringe and tubing catheter. In some cases this has resulted in leakages of contrast media during use.

 

The affected products' details are as follows:

PIP Code

Product Description

Supplier

Affected Batch

ALLIANCE DO NOT STOCK

Optiray 300mg I/ml Solution for Injection or Infusion

Guerbet Laboratories Limited

20H1482U

20H1452U

20F1342U

20F1312U

20F1292U

ALLIANCE DO NOT STOCK

Optiray 350mg I/ml Solution for Injection or Infusion

Guerbet Laboratories Limited

20H1482U

20H1452U

20F1342U

20F1312U

20F1292U

 

Alliance do not stock these products and therefore we are not accepting stock returns.



For medical information and stock enquiries, please contact Guertbet Laboratories Limited on Tel: 01217338542

 

E-mail (medical enquiries): uk.sales@guerbet.com and Krupa.mehta@guerbet.com

 

Email (stock enquiries): uk.sales@guerbet.com

 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.